WINDTREE THERAPEUTICS INC /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $82920.00 per share as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2025-11-19
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $82920.00.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $78185.50.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $78185.50.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $77533.16.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-09-30 | $82920.00 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $78185.50 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $78185.50 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $77533.16 10-K · filed 2025-04-15 | |
| 2024-09-30 | $1561.94 10-Q · filed 2024-11-26 | |
| 2024-06-30 | $1533.64 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $1678.09 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $94.53 10-K · filed 2024-04-16 | |
| 2023-06-30 | $94.61 10-Q · filed 2023-11-09 | $382.01 10-Q · filed 2023-08-07 |
| 2023-03-31 | $377.17 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $382.00 10-K · filed 2023-03-31 | |
| 2022-09-30 | $7.65 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $7.85 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $8.06 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $9.78 10-K · filed 2022-03-31 | |
| 2021-09-30 | $10.08 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $11.40 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $11.50 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $15.56 10-K · filed 2021-03-29 | |
| 2020-09-30 | $15.76 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $17.37 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $17.37 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $5.85 10-K · filed 2020-04-03 | |
| 2019-09-30 | $5.79 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $5.79 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $5.89 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $6.78 10-K/A · filed 2019-04-23 | |
| 2018-09-30 | $155.20 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $159.40 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $162.20 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $164.00 10-K · filed 2018-04-17 | |
| 2017-09-30 | $9.13 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $8.45 10-Q · filed 2017-08-21 | |
| 2017-03-31 | $9.07 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $14.81 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |